$276 Million is the total value of New Leaf Venture Partners, L.L.C.'s 22 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | Sell | ARVINAS INC | $105,921,000 | -1.5% | 1,289,521 | -1.4% | 38.38% | +23.8% |
| HARP | HARPOON THERAPEUTICS INC | $23,833,000 | -4.4% | 3,156,699 | 0.0% | 8.64% | +20.0% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $23,740,000 | -8.0% | 1,553,661 | 0.0% | 8.60% | +15.6% | |
| RALLYBIO CORPORATION | $21,957,000 | -45.7% | 2,301,603 | 0.0% | 7.96% | -31.8% | ||
| PASG | PASSAGE BIO | $15,862,000 | -36.2% | 2,497,922 | 0.0% | 5.75% | -19.9% | |
| DICE THERAPEUTICS INC | $14,090,000 | -22.7% | 556,693 | 0.0% | 5.10% | -2.9% | ||
| DCPH | DECIPHERA PHARMACEUTICALS INC | $11,818,000 | -71.2% | 1,209,571 | 0.0% | 4.28% | -63.9% | |
| SRRA | SIERRA ONCOLOGY INC | $8,905,000 | -0.8% | 409,611 | 0.0% | 3.23% | +24.6% | |
| APTX | APTINYX INC | $8,785,000 | +14.1% | 3,290,079 | 0.0% | 3.18% | +43.3% | |
| CMRX | CHIMERIX INC | $7,874,000 | +3.9% | 1,224,600 | 0.0% | 2.85% | +30.5% | |
| ALEC | ALECTOR INC | $7,012,000 | -9.5% | 339,569 | 0.0% | 2.54% | +13.6% | |
| RENOVACOR CORPORATION | $5,370,000 | -14.9% | 697,436 | 0.0% | 1.95% | +6.9% | ||
| AMYT | AMRYT PHARMA PLC | $4,857,000 | -10.3% | 449,737 | 0.0% | 1.76% | +12.7% | |
| COGT | COGENT BIOSCIENCES INC. | $4,303,000 | +2.0% | 501,530 | 0.0% | 1.56% | +28.1% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $4,006,000 | +35.0% | 141,000 | 0.0% | 1.45% | +69.5% | |
| ARAV | ARAVIVE INC | $2,073,000 | -41.1% | 946,423 | 0.0% | 0.75% | -26.1% | |
| OBSV | OBSEVA SA | $1,792,000 | -36.0% | 900,501 | 0.0% | 0.65% | -19.7% | |
| AVRO | AVROBIO INC | $1,215,000 | -31.0% | 315,550 | 0.0% | 0.44% | -13.4% | |
| PDSB | PDS BIOTECHNOLOGY CORP | $950,000 | -45.6% | 117,242 | 0.0% | 0.34% | -31.7% | |
| XFOR | X4 PHARMACEUTICALS INC | $767,000 | -56.7% | 335,000 | 0.0% | 0.28% | -45.6% | |
| ITRM | ITERUM THERAPEUTICS PLC | $571,000 | -29.8% | 1,456,303 | 0.0% | 0.21% | -11.5% | |
| ADXN | ADDEX THERAPEUTICS LTD | $315,000 | -30.2% | 50,000 | 0.0% | 0.11% | -12.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.